Loading profile
Loading sourced facts.
01 Finding sources
02 Reading evidence
03 Filing the card
Loading profile
01 Finding sources
02 Reading evidence
03 Filing the card
LatchBio sells a cloud data and compute platform for biotech R&D teams that lets bench biologists run bioinformatics workflows without writing code or managing cloud infrastructure.
Raised $33M across disclosed rounds.[18]
Series A closed June 2022, led by Coatue.[1][3]
post-money valuation is not publicly disclosed.
Named investors include Lux Capital, Coatue, General Catalyst, Haystack, Fifty Years, Hummingbird Ventures, Caffeinated Capital, Backend Capital, Alec Nielsen.[1][2][18]
Kyle Giffin, Co-Founder[20][21][25][11][12]
Kenny Workman, Co-Founder[20][21][25][11][12]
Alfredo Andere, Co-Founder and CEO[20][21][25][11][12]
Joel Simonoff, AI Engineer[22][23][24][26][27][13][14]
Ayush Kamat, Member of Technical Staff[22][23][24][26][27][13][14]
Ben Kesler, Bioinformatics Engineer[22][23][24][26][27][13][14]
Kyle Giffin Co, CEO
May 2026 · biospace.com
verified
May 2026 · biospace.com
reported
May 2026 · luxcapital.com
reported
LatchBio sells a cloud data and compute platform for biotech R&D teams that lets bench biologists run bioinformatics workflows without writing code or managing cloud infrastructure.
Kyle Co[22][23][24][26][27][13][14]
Doe[22][23][24][26][27][13][14]
First Last[22][23][24][26][27][13][14]
John Doe[22][23][24][26][27][13][14]
Hannah Han L., Head of Product[22][23][24][26][27][13][14]
DNAnexus · dnanexus.com · Same buyer (pharma and biotech R&D teams), same workflow (cloud-hosted bioinformatics pipeline execution), and same budget (computational biology / informatics infrastructure spend); named in the omics solution provider market map authored by LatchBio's own...[31]
Terra (Broad Institute / Microsoft) · terra.bio · Same workflow (no-infrastructure bioinformatics pipeline execution for bench and computational biologists) and same buyer segment (academic and pharma R&D teams); named in the omics solution provider market map alongside LatchBio.[31]
Benchling · benchling.com · Same buyer (pharma and biotech R&D teams) and overlapping budget (R&D informatics / lab software); competes for the role of system of record for biological data in the same 300+ pharma and biotech team segment LatchBio targets.[18][32]
Seven Bridges Genomics · sevenbridges.com · Same workflow (managed cloud execution of bioinformatics pipelines including RNA-Seq and variant calling) and same buyer (pharma and academic genomics teams); named in the omics solution provider market map as a direct category peer.[31]
Filled in the side panel for invited readers. This card carries sourced facts only.
May 2026 · blog.latch.bio
company
May 2026 · cbinsights.com
vendor
May 2026 · pitchbook.com
vendor
May 2026 · mlberkeley.substack.com
reported